Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. Currently, surgical resection, liver transplantation, and local ablation are considered curative therapeutic practices for HCC. The diagnosis of HCC without pathologic confirmation is achieved by analyzing serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Kai, Dai, Zhi, Zhou, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177612/
https://www.ncbi.nlm.nih.gov/pubmed/24252133
http://dx.doi.org/10.1186/2050-7771-1-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177612/
https://www.ncbi.nlm.nih.gov/pubmed/24252133
http://dx.doi.org/10.1186/2050-7771-1-10

Ejemplares similares